Finasteride USP For Compounding (API)

Finasteride USP For Compounding (API) is a high-quality active pharmaceutical ingredient used primarily for the treatment of androgenic alopecia (male pattern baldness) and benign prostatic hyperplasia (BPH). As an essential tool in personalized medicine, it allows healthcare professionals to compound tailored formulations that meet specific patient needs. Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to hair loss and prostate enlargement. This API supports prostate health, promotes hair regrowth, and adheres to rigorous quality standards, ensuring safety and efficacy in dermatological and urological therapies.

Finasteride USP is an active pharmaceutical ingredient (API) used in the compounding of medications. It is a synthetic 5-alpha-reductase inhibitor that is primarily used to treat benign prostatic hyperplasia (BPH) and male pattern hair loss. It works by inhibiting the conversion of testosterone to dihydrotestosterone, reducing the size of the prostate gland and promoting hair growth. Finasteride USP can be prescribed, under supervision, by a licensed healthcare provider for compounding into various formulations for individual patients. It is important to note that finasteride USP should not be handled or used by women, especially pregnant women, due to the potential risk of harm to a developing male fetus.